SSelectStock

NIVABUPANiva Bupa Health Insurance Company Limited

Insurance · Insurance - Life · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.

79.93
0.64%
55Decent

Mkt Cap
₹14,779 Cr
P/E
112.6
P/B
4.1
Div Yield
0.00%
52W High
₹91.40
52W Low
₹67.50

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)14,778.90
P/E112.58
P/B4.12
PEG1.33
ROE %10.65
ROCE %
Debt / Equity0.10
EPS0.71
Revenue Growth %26.80
Profit Growth %90.20
Dividend Yield %0.00
Promoter Holding %76.84
FII Holding %15.68
DII Holding %
Beta0.40

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on NIVABUPA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 57%

The picture

  • Revenue growth: 26.8% YoY
  • Profit growth: 90.2% YoY
  • Debt/Equity: 0.10
  • Price vs SMA200: above
  • Golden cross setup: SMA50 above SMA200
  • 6-month return: +14.1%

Bull case

  • Revenue growth: 26.8% YoY
  • Profit growth: 90.2% YoY
  • Debt/Equity: 0.10
  • Price vs SMA200: above

Bear case

  • ROE: 10.7%
  • Valuation vs sector: P/E 112.6 vs sector 59.5
  • RSI: 36
  • MACD: bearish

Key risks

  • ROE: 10.7%
  • Valuation vs sector: P/E 112.6 vs sector 59.5

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹79.93
Stop Loss
₹77.58
risk 2.9%
Target 1 (1.5R)
₹83.46
+4.4%
Target 2 (3R)
₹86.99
+8.8%
Support (20d)
₹78.36
Resistance (52w)
₹91.40
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹2.35/share
ATR (volatility)
₹1.80
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹1.80). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental71
Technical35
Momentum44
Risk (safety)83

Peers — Insurance

NIACL 0.53%
67
LICI 0.37%
64
STARHEALTH 2.35%
63
POLICYBZR 0.15%
62
RELIGARE 0.76%
60
CANHLIFE 0.29%
53